Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher McGuigan

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Novel bicyclic furanopyrimidines with dual anti-VZV and -HCMV activityChristopher McGuigan, Andrea Brancale, Graciela Andrei, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2016
ProTides of BVdU as potential anticancer agents upon efficient intracellular delivery of their activated metabolitesSahar Kandil, Jan Balzarini, Stephanie Rat, et al.
Journal of Experimental Therapeutics & Oncology|August 26, 2010
The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapyJane Lane, Tracey A Martin, Christopher McGuigan, et al.
British Journal of Pharmacology|May 8, 2004
Enhanced inhibition of the EDHF phenomenon by a phenyl methoxyalaninyl phosphoramidate derivative of dideoxyadenosineTudor M Griffith, Andrew T Chaytor, David H Edwards, et al.
Antiviral Chemistry & Chemotherapy|January 14, 2005
Non-nucleoside structures retain full anti-HCMV potency of the dideoxy furanopyrimidine familyOlivier Bidet, Christopher McGuigan, Robert Snoeck, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
What would improve MS clinic services for cognition? - A stakeholder panel and survey explorationDawn Langdon, Mhairi Coutts, Christopher McGuigan, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2004
Synthesis and antiviral evaluation of some 3'-fluoro bicyclic nucleoside analoguesChristopher McGuigan, Antonella Carangio, Robert Snoeck, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2008
Successful kinase bypass with new acyclovir phosphoramidate prodrugsChristopher McGuigan, Marco Derudas, Joachim J Bugert, et al.
Molecular Pharmacology|January 26, 2002
Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinaseRebecca Sienaert, Lieve Naesens, Andrea Brancale, et al.
Journal of Medicinal Chemistry|June 4, 2021
Single Diastereomers of the Clinical Anticancer ProTide Agents NUC-1031 and NUC-3373 Preferentially Target Cancer Stem Cells <i>In Vitro</i>Magdalena Slusarczyk, Michaela Serpi, Essam Ghazaly, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Novel bicyclic furanopyrimidines with dual anti-VZV and -HCMV activityChristopher McGuigan, Andrea Brancale, Graciela Andrei, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2016
ProTides of BVdU as potential anticancer agents upon efficient intracellular delivery of their activated metabolitesSahar Kandil, Jan Balzarini, Stephanie Rat, et al.
Journal of Experimental Therapeutics & Oncology|August 26, 2010
The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapyJane Lane, Tracey A Martin, Christopher McGuigan, et al.
British Journal of Pharmacology|May 8, 2004
Enhanced inhibition of the EDHF phenomenon by a phenyl methoxyalaninyl phosphoramidate derivative of dideoxyadenosineTudor M Griffith, Andrew T Chaytor, David H Edwards, et al.
Antiviral Chemistry & Chemotherapy|January 14, 2005
Non-nucleoside structures retain full anti-HCMV potency of the dideoxy furanopyrimidine familyOlivier Bidet, Christopher McGuigan, Robert Snoeck, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
What would improve MS clinic services for cognition? - A stakeholder panel and survey explorationDawn Langdon, Mhairi Coutts, Christopher McGuigan, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2004
Synthesis and antiviral evaluation of some 3'-fluoro bicyclic nucleoside analoguesChristopher McGuigan, Antonella Carangio, Robert Snoeck, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2008
Successful kinase bypass with new acyclovir phosphoramidate prodrugsChristopher McGuigan, Marco Derudas, Joachim J Bugert, et al.
Molecular Pharmacology|January 26, 2002
Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinaseRebecca Sienaert, Lieve Naesens, Andrea Brancale, et al.
Journal of Medicinal Chemistry|June 4, 2021
Single Diastereomers of the Clinical Anticancer ProTide Agents NUC-1031 and NUC-3373 Preferentially Target Cancer Stem Cells <i>In Vitro</i>Magdalena Slusarczyk, Michaela Serpi, Essam Ghazaly, et al.
Pageof 16